Publication Date
| In 2026 | 0 |
| Since 2025 | 0 |
| Since 2022 (last 5 years) | 0 |
| Since 2017 (last 10 years) | 1 |
| Since 2007 (last 20 years) | 2 |
Descriptor
| Autism | 2 |
| Behavior Modification | 2 |
| Behavior Problems | 2 |
| Children | 2 |
| Pervasive Developmental… | 2 |
| Sleep | 2 |
| Antisocial Behavior | 1 |
| Arousal Patterns | 1 |
| Child Behavior | 1 |
| Cognitive Restructuring | 1 |
| Comparative Analysis | 1 |
| More ▼ | |
Author
| Bossie, Cynthia A. | 1 |
| Chan, Wai Sze | 1 |
| Curtis, Ashley F. | 1 |
| Davenport, Mattina | 1 |
| Deroche, Chelsea B. | 1 |
| Dunbar, Fiona | 1 |
| Mazurek, Micah O. | 1 |
| McCann, Dillon | 1 |
| McCrae, Christina S. | 1 |
| McGovney, Kevin | 1 |
| McLean, Deija | 1 |
| More ▼ | |
Publication Type
| Journal Articles | 2 |
| Reports - Research | 2 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
| Aberrant Behavior Checklist | 2 |
| Autism Diagnostic Observation… | 1 |
What Works Clearinghouse Rating
Peer reviewed
Direct linkMcCrae, Christina S.; Chan, Wai Sze; Curtis, Ashley F.; Nair, Neetu; Deroche, Chelsea B.; Munoz, Melissa; Takamatsu, Stephanie; McLean, Deija; Davenport, Mattina; Muckerman, Julie E.; Takahashi, Nicole; McCann, Dillon; McGovney, Kevin; Sahota, Pradeep; Mazurek, Micah O. – Autism: The International Journal of Research and Practice, 2021
Insomnia is common in children with autism. Cognitive behavioral treatment for childhood insomnia may improve sleep and functioning in children with autism and their parents, but delivery involving multiple office visits limits accessibility. This single-arm pilot study tested telehealth delivery of eight-session cognitive behavioral treatment for…
Descriptors: Autism, Pervasive Developmental Disorders, Sleep, Cognitive Restructuring
Pandina, Gahan J.; Bossie, Cynthia A.; Youssef, Eriene; Zhu, Young; Dunbar, Fiona – Journal of Autism and Developmental Disorders, 2007
Subgroup analysis of children (5-12 years) with autism enrolled in an 8-week, double-blind, placebo-controlled trial of risperidone for pervasive developmental disorders. The primary efficacy measure was the Aberrant Behavior Checklist-Irritability (ABC-I) subscale. Data were available for 55 children given risperidone (n = 27) or placebo (n =…
Descriptors: Autism, Drug Therapy, Children, Behavior Modification
